Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Concept Videos

Angle Closure Glaucoma: Treatment01:28

Angle Closure Glaucoma: Treatment

Angle-closure glaucoma, or closed-angle glaucoma, is an eye condition where the iris bulges out and blocks the iridocorneal angle, resulting in a buildup of aqueous humor and increased intraocular pressure. Immediate medical attention is necessary due to the sudden onset of symptoms. The treatment for angle-closure glaucoma includes short-term and long-term approaches. Short-term treatment involves using eye drops like pilocarpine to lower intraocular pressure by increasing aqueous humor...
Open Angle Glaucoma: Treatment01:27

Open Angle Glaucoma: Treatment

In open-angle glaucoma, the iridocorneal angle remains open, but the trabecular meshwork becomes stiff, slowing down the outflow of aqueous humor. This causes a buildup of aqueous humor in the anterior chamber, leading to a sudden increase in intraocular pressure. The treatment for open-angle glaucoma focuses on reducing the elevated intraocular pressure by either decreasing the secretion of aqueous humor or increasing its outflow.
Drugs such as carbonic anhydrase inhibitors, α2- and...

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

International validation of a staging system for ciliary body and choroidal melanomas using estimated tumour volume.

Canadian journal of ophthalmology. Journal canadien d'ophtalmologie·2026
Same author

Circulating Tumor Cells in Uveal Melanoma: Multi-Marker Detection and Association With Disease State.

Investigative ophthalmology & visual science·2026
Same author

Whole-Genome Landscape of Retinal Hemangioblastomas.

Translational vision science & technology·2026
Same author

Genetic Background Predicts Uveal Melanoma Patients' Outcomes.

Ophthalmology science·2025
Same author

Methylated CfDNA may distinguish between high- and intermediate-risk uveal melanoma: a pilot study.

Cancer cell international·2025
Same author

Accuracy of day-to-day patient positioning in ocular proton therapy with a dedicated beamline.

PloS one·2025

Related Experiment Video

Updated: May 25, 2026

Retinal Pigment Epithelium Transplantation in a Non-human Primate Model for Degenerative Retinal Diseases
11:20

Retinal Pigment Epithelium Transplantation in a Non-human Primate Model for Degenerative Retinal Diseases

Published on: June 14, 2021

[Micro-incision transconjunctival vitrectomy--a safe alternative for conventional vitrectomy].

Emine Kilic1, Robert W A M Kuijpers

  • 1Erasmus MC, afd. Oogheelkunde, Rotterdam, the Netherlands. e.kilic@erasmusmc.nl

Nederlands Tijdschrift Voor Geneeskunde
|January 20, 2012
PubMed
Summary

Vitrectomy surgery involves removing vitreous gel to treat eye conditions. Newer, smaller incisions (23G and 25G vitrectomies) offer less trauma for simpler cases, while traditional 20G vitrectomy remains best for complex issues.

More Related Videos

Implantation Protocol of the Foldable Capsular Vitreous Body for Complex Vitreoretinal Surgery
04:36

Implantation Protocol of the Foldable Capsular Vitreous Body for Complex Vitreoretinal Surgery

Published on: April 14, 2026

Optimized Minimally Invasive Transscleral Subretinal Injection Technique in Mouse
06:46

Optimized Minimally Invasive Transscleral Subretinal Injection Technique in Mouse

Published on: July 25, 2025

Related Experiment Videos

Last Updated: May 25, 2026

Retinal Pigment Epithelium Transplantation in a Non-human Primate Model for Degenerative Retinal Diseases
11:20

Retinal Pigment Epithelium Transplantation in a Non-human Primate Model for Degenerative Retinal Diseases

Published on: June 14, 2021

Implantation Protocol of the Foldable Capsular Vitreous Body for Complex Vitreoretinal Surgery
04:36

Implantation Protocol of the Foldable Capsular Vitreous Body for Complex Vitreoretinal Surgery

Published on: April 14, 2026

Optimized Minimally Invasive Transscleral Subretinal Injection Technique in Mouse
06:46

Optimized Minimally Invasive Transscleral Subretinal Injection Technique in Mouse

Published on: July 25, 2025

Area of Science:

  • Ophthalmology
  • Surgical Techniques
  • Retinal Surgery

Context:

  • Vitrectomy is a surgical procedure to remove vitreous gel from the eye.
  • Advancements in vitrectomy include the development of smaller gauge instruments.
  • These innovations aim to reduce operative time and ocular trauma.

Purpose:

  • To compare the efficacy and application of different vitrectomy gauges.
  • To highlight the suitability of newer vitrectomy techniques for specific ophthalmic conditions.
  • To inform surgical choices based on the complexity of vitreo-retinal defects.

Summary:

  • Smaller gauge vitrectomies (23G and 25G) are effective for less complex conditions like macular membranes and vitreous hemorrhage.
  • Conventional 20G vitrectomy is preferred for complex cases, including extensive tractional membranes and managing dropped lens fragments.
  • The choice of vitrectomy gauge depends on the specific ophthalmic defect being treated.

Impact:

  • Improved patient outcomes through minimally invasive techniques.
  • Reduced recovery times and patient discomfort.
  • Enhanced surgical precision and safety in treating a range of vitreoretinal disorders.